Use the PHQ-9 for adult depression screening in primary care, or the PHQ-2 as a two-question first step that leads to the PHQ-9. Use the CESD-R when a research protocol names it, and the DASS-21 when you want separate depression, anxiety and stress scores. Use the HAM-D or MADRS when a trained rater needs to grade severity or track change in specialist care or a trial. None of these scores makes a diagnosis. Each one grades reported or observed symptoms for a clinical assessment to interpret.
Which tool fits which job
| Job | Best fit | Why |
|---|---|---|
| Adult screening in primary care | PHQ-9 | Nine DSM-IV criteria, severity bands and a safety item in one short form |
| Brief first step | PHQ-2, then the PHQ-9 if positive | Two questions that decide who completes the full PHQ-9 |
| Research or population survey | CESD-R | 20 items and an algorithm that sorts answers into DSM-style categories |
| Separate depression, anxiety and stress scores | DASS-21 | Three seven-item domains on a dimensional scale |
| Clinician-rated severity | HAM-D | Interview-based rating used widely in depression treatment research |
| Clinician-rated change during treatment | MADRS | Ten items chosen because they changed most with antidepressant treatment |
The USPSTF recommends depression screening for all adults, including pregnant and postpartum people and adults 65 or older (June 2023). Its evidence review covered PHQ forms, the CES-D, the GDS and the EPDS, among others. Positive screens should lead to diagnostic evaluation and evidence-based care. The Task Force found little evidence on how often to screen, so use clinical judgment about risk factors, comorbid conditions and life events to set the interval.
Depression scales compared side by side
| Tool | Who completes it | Items | Timeframe | Score range | Bands or cutoff | Safety item | Best fit |
|---|---|---|---|---|---|---|---|
| PHQ-9 | Patient (self-report) | 9 | Past 2 weeks | 0-27 | 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe | Item 9 | Adult screening and severity tracking |
| PHQ-2 | Patient (self-report) | 2 | Past 2 weeks | 0-6 | 3 or more is a positive screen | None | First step before the PHQ-9 |
| CESD-R | Patient (self-report) | 20 | Past week; the top answer covers 2 weeks | 0-60 collapsed total | 16 or more; algorithm categories up to a full major depressive episode | Items 14 and 15 | Research and population surveys |
| DASS-21 | Patient (self-report) | 21, seven per domain | Past week | 0-42 per domain after doubling | Five labels per domain, from normal to extremely severe | None | Separate depression, anxiety and stress scores |
| HAM-D-17 | Trained clinician | 17 | Set by the edition | 0-52 | Varies by source; Zimmerman et al. (2013) start mild at 8, moderate at 17, severe at 24 | Item 3 | Severity rating in specialist care and trials |
| MADRS | Trained clinician | 10 | Set by the protocol | 0-60 | Remission cutoffs vary; 10 or less matches a HAM-D of 7 or less | Item 10 | Measuring change in specialist care and trials |
Each figure in this table is sourced in the section on that tool below.
Safety items and follow-up
The PHQ-9, CESD-R, HAM-D and MADRS each include an item on suicidal thoughts. The PHQ-2 and DASS-21 have no item that asks directly about suicidal thoughts or self-harm. A service using either one needs a separate safety question. Any endorsed safety item needs direct, timely follow-up, whatever the total. A low total cannot cancel an endorsed item, and one questionnaire item is not a structured suicide-risk assessment. The USPSTF (2023) found the evidence insufficient to weigh the benefits and harms of screening adults for suicide risk. Follow your organization's own risk assessment protocol.
If you need help now. In the US, Call 988 or text 988. Call 911 if you are in immediate danger. Outside the US, contact your local emergency number or find support in your country.
PHQ-9 vs HAM-D vs MADRS
The PHQ-9 is completed by the patient, while the HAM-D and MADRS are clinician ratings. Apart from the remission equivalence described below, treat their totals as separate scales.
| PHQ-9 | HAM-D-17 | MADRS | |
|---|---|---|---|
| Who rates | Patient | Trained clinician, by interview | Trained clinician, by interview and observation |
| Items and range | 9 items, 0-27 | 17 items, 0-52 | 10 items, 0-60 |
| Emphasis | The nine DSM-IV criteria for major depression | Mood plus insomnia, anxiety, somatic symptoms, weight and insight | Mood and cognitive symptoms; sleep and appetite are the only bodily items |
| Change evidence | Tracked interview-defined improvement and worsening | The reference scale in much treatment research | Built to detect change; separated treatment responders better than the HAM-D |
| Best use | Screening and monitoring between visits | Trials and specialist care that need comparability with HAM-D studies | Trials and specialist care focused on treatment response |
PHQ-9 vs HAM-D
The PHQ-9 asks patients how often each of the nine DSM-IV criteria occurred over two weeks. The HAM-D-17 is a clinician rating, and 10 of its 17 items cover insomnia, anxiety, somatic symptoms, health worry or weight loss. Cameron et al. (2011) tested both in 267 primary care patients with diagnosed depression. Against HRSD-17 ratings of at least moderate severity (APA criteria), the PHQ-9 had an AUC of 0.90. Its best cutoff for that task was 12, with 77% sensitivity and 79% specificity. The authors concluded that no self-report scale they tested aligned closely enough with the HRSD-17 to replace it for severity-based treatment decisions.
PHQ-9 vs MADRS
Montgomery and Åsberg (1979) built the MADRS from the 10 items that changed most during antidepressant treatment. It separated treatment responders from non-responders better than the Hamilton scale. The PHQ-9 also tracks change. Löwe et al. (2004) followed 167 medical outpatients for about 12 months. PHQ-9 change scores had an effect size of -1.33 when interview-rated depression improved, -0.21 when it was unchanged and 0.47 when it worsened. That study measured the PHQ-9 against a diagnostic interview, not against the MADRS. Use the MADRS when a trained rater measures response in specialist care or a trial, and the PHQ-9 when the patient reports between visits.
MADRS vs HAM-D
Both are clinician ratings, but they weight symptoms differently. HAM-D-17 items run 0-4 or 0-2 and give more weight to sleep, anxiety and somatic complaints, while every MADRS item runs 0-6. Zimmerman et al. (2004) rated 303 outpatients on both scales. A MADRS score of 10 or less best matched the usual HAM-D remission cutoff of 7 or less. Use the scale your protocol names. Without one, the HAM-D gives comparability with older treatment studies and the MADRS gives a design built for sensitivity to change.
PHQ-9: adult primary care screening
The PHQ-9 scores each of the nine DSM-IV criteria for major depression from 0 to 3, for a total of 0 to 27. The original study included 6,000 primary care and obstetrics-gynecology patients (Kroenke et al., 2001). Totals of 5, 10, 15 and 20 marked mild, moderate, moderately severe and severe depression. In 580 patients checked against a mental health professional interview, a score of 10 or more had 88% sensitivity and 88% specificity for major depression.
A 2019 individual participant data meta-analysis pooled 29 studies and 6,725 participants assessed with semistructured interviews (Levis et al., 2019). A cutoff of 10 or more gave 88% sensitivity and 85% specificity, maximized combined accuracy, and held regardless of age. Item 9 asks about thoughts of death or self-harm. When physical illness, pregnancy or medication could explain the sleep, energy and appetite items, read the item pattern alongside the total.
PHQ-2: a first step that leads to the PHQ-9
The PHQ-2 is the first two PHQ-9 items, depressed mood and loss of interest, with a total of 0 to 6. In the original study, a score of 3 or more had 83% sensitivity and 92% specificity for major depression (Kroenke et al., 2003). A 2020 meta-analysis of 100 studies and 44,318 participants found lower sensitivity at that cutoff (Levis et al., 2020). With semistructured interviews, a cutoff of 3 gave 72% sensitivity and 85% specificity, and a cutoff of 2 gave 91% and 67%.
The same analysis tested a two-step sequence: a PHQ-2 of 2 or more, then a PHQ-9 of 10 or more. The sequence had 82% sensitivity and 87% specificity, against 86% and 85% for the PHQ-9 alone in the same studies. It cut the number of full PHQ-9s needed by 57%. Survey Doctor flags a PHQ-2 of 3 or more as positive, so set your own threshold for moving to the PHQ-9 if you prefer 2. For a fuller comparison, see PHQ-2 vs PHQ-9.
CESD-R: research and population surveys
The CESD-R has 20 items in nine DSM symptom groups, according to the official CESD-R guide. Answers range from less than one day in the past week to nearly every day for two weeks. The top two options both score 3, which gives a 0-60 total on the original CES-D scale. A total of 16 or more marks subthreshold symptoms, unless the answers meet the algorithm for a possible, probable or full major depressive episode. Items 14 and 15 form the suicidal ideation group.
Van Dam and Earleywine (2011) validated the CESD-R in a community sample of 7,389 and a student sample of 245. They reported high internal consistency, and the algorithm produced depression base rates consistent with epidemiological results. The CESD-R suits studies that need broad symptom coverage and DSM-style categories, though it is longer and less familiar in primary care. Survey Doctor displays this 0-60 total beside the category. The CESD-R score guide explains the categories.
DASS-21: three separate domains
The DASS-21 has 21 items, seven each for depression, anxiety and stress, rated on a four-point scale for the past week (DASS overview). Its depression scale covers dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest, anhedonia and inertia. The developers' FAQ says to multiply each DASS-21 scale by 2 to compare it with DASS-42 norms. Survey Doctor shows those doubled 0-42 scores, so do not double them again.
The severity labels come from the DASS manual, and the developers describe the scales as dimensional, with no direct link to DSM or ICD categories. Use the DASS-21 when a protocol needs depression, anxiety and stress scored separately from one form. For a direct comparison, see DASS-21 vs PHQ-9.
HAM-D: clinician-rated severity
Hamilton published the original scale in 1960 (Hamilton, 1960), and later editions changed the item count, anchors and interview method. The 17-item form rates mood, guilt, suicide, insomnia, work and interests, retardation, agitation, anxiety, somatic symptoms, weight loss and insight. Its total runs from 0 to 52. An early test-retest study found only fair or poor agreement on most items. Williams (1988) added a structured interview guide, which substantially improved agreement, and described the HAM-D as the most widely used scale in depression treatment research.
Severity bands vary by source. In 627 outpatients with major depression, Zimmerman et al. (2013) recommended 0-7 for no depression, 8-16 mild, 17-23 moderate and 24 or more severe. Survey Doctor's HAM-D results use these ranges, shown on the HAM-D page, so name the scheme when you report a band. Item 3 rates suicide.
MADRS: clinician-rated change
The MADRS has 10 items, each rated 0 to 6, for a total of 0 to 60. Montgomery and Åsberg (1979) started from the 17 most common symptoms of primary depressive illness. They kept the 10 items that changed most with treatment in 64 patients from four antidepressant studies, and inter-rater reliability was high. The items cover apparent and reported sadness, inner tension, sleep, appetite, concentration, lassitude, inability to feel, pessimistic thoughts and suicidal thoughts, which is item 10.
Studies have used various MADRS cutoffs to define remission, so state the one you apply (Zimmerman et al., 2004). The same study's match of 10 or less with HAM-D remission helps when you compare trials that used different scales.
BDI-II and HADS
The BDI-II and HADS also come up in depression scale comparisons, and Survey Doctor does not offer either one. The BDI-II has 21 items for ages 13 to 80 and covers two weeks instead of its predecessor's one. It takes about 5 minutes, according to its publisher, Pearson, which sells the forms. In the Cameron et al. (2011) primary care study, the BDI-II identified at least moderate HRSD-17 severity with an AUC of 0.86. The PHQ-9 scored 0.90 and the HADS depression scale 0.84.
Zigmond and Snaith (1983) developed the HADS for hospital medical outpatient clinics, with separate anxiety and depression scales. Cameron et al. (2008) gave the PHQ-9 and HADS to 1,063 primary care patients. Both were similarly responsive to change, with effect sizes of 0.99 and 1.0. The PHQ-9 placed more patients in its moderate or severe bands, so the two scales' severity labels are not interchangeable.
Which tools Survey Doctor offers
You can take the PHQ-9 and PHQ-2 on Survey Doctor without an account. The CESD-R and DASS-21 reference pages explain how each one is scored. The HAM-D and MADRS are clinician ratings, so they are not offered for self-report. The MADRS page explains how its ten clinician ratings are scored. To set up screening, see the primary care depression screening workflow. For older adults, compare the GDS-15 and PHQ-9.
Comparing scores across tools
A PHQ-9 of 15 and a HAM-D of 15 describe different things, because the scales differ in content, rater and range. To track change, repeat the same tool, edition, timeframe and administration method, and compare item patterns as well as totals. When a protocol needs both views, pair a patient-completed PHQ-9 with a clinician-rated HAM-D or MADRS and report each on its own scale. The PHQ-9 then shows how the patient describes the past two weeks, and the clinician rating shows what a trained interviewer observed.
